246 related articles for article (PubMed ID: 24486913)
1. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications.
Kruse AM; Meenach SA; Anderson KW; Hilt JZ
Acta Biomater; 2014 Jun; 10(6):2622-9. PubMed ID: 24486913
[TBL] [Abstract][Full Text] [Related]
2. Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating.
Meyer H; Winkler F; Kunz P; Schmidt AM; Hamacher A; Kassack MU; Janiak C
Inorg Chem; 2015 Dec; 54(23):11236-46. PubMed ID: 26595858
[TBL] [Abstract][Full Text] [Related]
3.
Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125
[TBL] [Abstract][Full Text] [Related]
4. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
Hoopes P; Tate J; Ogden J; Strawbridge R; Fiering S; Petryk A; Cassim S; Giustini A; Demidenko E; Ivkov R; Barry S; Chinn P; Foreman A
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810P. PubMed ID: 25346583
[TBL] [Abstract][Full Text] [Related]
5. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
8. Highly Optimized Iron Oxide Embedded Poly(Lactic Acid) Nanocomposites for Effective Magnetic Hyperthermia and Biosecurity.
Ryu C; Lee H; Kim H; Hwang S; Hadadian Y; Mohanty A; Park IK; Cho B; Yoon J; Lee JY
Int J Nanomedicine; 2022; 17():31-44. PubMed ID: 35023918
[TBL] [Abstract][Full Text] [Related]
9. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
10. Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia.
Albarqi HA; Wong LH; Schumann C; Sabei FY; Korzun T; Li X; Hansen MN; Dhagat P; Moses AS; Taratula O; Taratula O
ACS Nano; 2019 Jun; 13(6):6383-6395. PubMed ID: 31082199
[TBL] [Abstract][Full Text] [Related]
11. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid.
Beyk J; Tavakoli H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2199-2209. PubMed ID: 31309302
[TBL] [Abstract][Full Text] [Related]
12. Induced heat property of polyethyleneglycol-coated iron oxide nanoparticles with dispersion stability for hyperthermia.
Jang DH; Lee YI; Kim KS; Park ES; Kang SC; Yoon TJ; Choa YH
J Nanosci Nanotechnol; 2013 Sep; 13(9):6098-102. PubMed ID: 24205608
[TBL] [Abstract][Full Text] [Related]
13. Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application.
Hoskins C; Min Y; Gueorguieva M; McDougall C; Volovick A; Prentice P; Wang Z; Melzer A; Cuschieri A; Wang L
J Nanobiotechnology; 2012 Jun; 10():27. PubMed ID: 22731703
[TBL] [Abstract][Full Text] [Related]
14. Duality of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment.
Espinosa A; Di Corato R; Kolosnjaj-Tabi J; Flaud P; Pellegrino T; Wilhelm C
ACS Nano; 2016 Feb; 10(2):2436-46. PubMed ID: 26766814
[TBL] [Abstract][Full Text] [Related]
15. Induction heating studies of dextran coated MgFe2O4 nanoparticles for magnetic hyperthermia.
Khot VM; Salunkhe AB; Thorat ND; Ningthoujam RS; Pawar SH
Dalton Trans; 2013 Jan; 42(4):1249-58. PubMed ID: 23138108
[TBL] [Abstract][Full Text] [Related]
16. Gold-coated iron oxide nanoparticles trigger apoptosis in the process of thermo-radiotherapy of U87-MG human glioma cells.
Neshastehriz A; Khosravi Z; Ghaznavi H; Shakeri-Zadeh A
Radiat Environ Biophys; 2018 Nov; 57(4):405-418. PubMed ID: 30203233
[TBL] [Abstract][Full Text] [Related]
17. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581
[TBL] [Abstract][Full Text] [Related]
18. Could FA-PG-SPIONs act as a hyperthermia sensitizing agent? An in vitro study.
Fakhimikabir H; Tavakoli MB; Zarrabi A; Amouheidari A; Rahgozar S
J Therm Biol; 2018 Dec; 78():73-83. PubMed ID: 30509670
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-induced vascular blockade in human prostate cancer.
Agemy L; Sugahara KN; Kotamraju VR; Gujraty K; Girard OM; Kono Y; Mattrey RF; Park JH; Sailor MJ; Jimenez AI; Cativiela C; Zanuy D; Sayago FJ; Aleman C; Nussinov R; Ruoslahti E
Blood; 2010 Oct; 116(15):2847-56. PubMed ID: 20587786
[TBL] [Abstract][Full Text] [Related]
20. N-Hydroxysuccinamide functionalized iron oxide nanoparticles conjugated with 5-flurouracil for hyperthermic therapy of malignant liver cancer cells by DNA repair disruption.
Veeramani S; Chandrababu L; Rajangam I; Singh NR; Al-Humaid L; Al-Dahmash ND; Balaji R; Chandrasekar N; Hwang MT
Int J Biol Macromol; 2023 Oct; 250():126001. PubMed ID: 37532190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
